Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
have enabled unprecedented control over light-matter interactions, catalyzing breakthroughs in imaging, nonlinear optics, and photonic computing. We leverage these developments to advance the field
-
modeling, laboratory experiments, and theoretical analyses, we seek to link microscopic processes with the macroscopic behavior of both engineering and natural systems and develop predictive tools
-
With a service-oriented and improvement-driven mindset, you and the team will contribute to the continuous development of innovative, data-driven approaches and projects in the context of open data and
-
for the suppliers? R7: How is the market/security impacted by the failure of a large nuclear power plant? This work will be performed using currently developed or in-development tools at RRE. Namely, Euroem , a
-
. Empa is a research institution of the ETH Domain. The Laboratory Chemical Energy Carriers and Vehicle Systems Laboratory conducts, develops and optimizes processes for renewable fuels. The group
-
reliable ground truth data for developing automated condition indicators from GPR measurements. Job description Support in planning and preparation of the experimental campaign (test track configuration
-
Systems.”Funded through an ETH Zurich Career Seed Award, this project aims to develop scientific machine learning frameworks that integrate physics-based modeling with neural network architectures. The goal
-
. Roman Zweifel) and CzechGlobe on Innovative technologies cross scales to disentangle carbon dioxide and evapotranspiration fluxes of forests (INETFLUX ). We aim to develop and validate new approaches
-
the structure and function of plant pathogen genomes. We are looking for someone with prior experience in either fungal or transposon comparative genomics, who can explore the diversity and evolution of Starship
-
generations to come. Join Roche, where every voice matters. The Position In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to